Washington University in St. Louis

Mission Statement

The ICTS accelerates clinical and translational research to improve health outcomes and benefit the well-being of our communities.

At a Glance

2

Educational Resources Posted

62

Consortium News Stories Posted

1

Events Posted

0

Opportunities Posted

86

Publications citing CTSA Program Grant

27

Users from Hub Registered
Contact PI Organization
Programs

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2021
Connect with Us

Consortium News

Washington University ICTS supported research shows that rapid saliva test screenings – aimed at early detection of the virus – contributed to exceedingly low transmission of the virus among students, teachers and staff in the six schools overseen by the Special School District of St. Louis County, the largest specialized education provider in Missouri.

Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a study by ICTS researchers at Washington University School of Medicine.

NIH Director, Francis Collins, MD, features ICTS research in his August 24th blog post, “The Amazing Brain: Tracking Molecular Events with Calling Cards”

Educational Content

Washington University

Washington University in St. Louis is recruiting for the fall program of our NIH-funded Entrepreneurship for Biomedicine (E4B) training program. E4B is free and taught fully online through Washington University in St. Louis. As an E4B trainee, you will work with biomedical research trainees from across the nation to innovatively solve problems in these challenging times, and develop skills in

Washington University
Dissemination and Implementation (D&I) science is the study of translation of research findings into practice. Eight pdf files: DIRC Intro to D&I Toolkit, Aims Toolkit, Barriers & Facilitators Toolkit, Implementation Outcomes Toolkit, Designs Toolkit, Implementation Strategies Toolkit, Guidelines Toolkit, Checklist for Writing IR Proposals DIRC Aims Toolkit DIRC Barriers & Facilitators Toolkit
Washington University in St. Louis School of Medicine
-
Washington University
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Cicely W. Fadel, MD, PhD from Harvard Medical School, hosted by Washington University in St. Louis will present her research on Gut Interrupted: Modeling Microbiome-Dependent Modulation of Premature Infant Intestinal Vulnerability

Poster Sessions

Washington University

As a result of the CTSA Program’s objective to strengthen multidisciplinary research infrastructure, hubs are uniquely poised to mobilize their vast resources to produce a rapid, nimble, multi-faceted approach to national public health emergencies. The Institute of Clinical and Translational Sciences, the CTSA grantee at Washington University in St. Louis, is a critical contributor to the

Washington University Poster
Washington University

The goal of the Precision Medicine function of the Washington University Institute of Clinical and Translational Sciences is to streamline precision medicine research processes across the university. Three separate initiatives supported this effort: (1) outreach to community and faculty members through surveys and focus groups to assess interest and concerns regarding participation in precision

Publications

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of

Eating disorder symptomatology, clinical impairment, and comorbid psychopathology in racially and ethnically diverse college women with eating disorders

To examine eating disorder (ED) symptomatology, related clinical impairment, and comorbid psychopathology in college women with EDs across five racial and two ethnic groups. Participants were 690 women from 28 US universities who screened positive for an ED. Thirteen variables assessing ED symptoms

The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature

The liver is a frequent site of malignancy, both primary and metastatic. The treatment goal of patients with liver cancer may include transarterial radioembolization (TARE). There are limited reports on the safety of hepatectomy following TARE. Our study's purpose is to review patients who have

Research and Operational Tools

Washington University

The Translational Science Benefits Model (TSBM) is a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures.

Title Authored Sort ascending Content type
COVID-19 transmission at school rare for children with disabilities September 13, 2021 Consortium News
Study supported by Washington University ICTS shows COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants September 13, 2021 Consortium News
Washington University ICTS supports research featured in NIH Director’s blog September 13, 2021 Consortium News
Washington University ICTS investigators in the field of Dissemination and Implementation ask: How can we use what we already know to make people healthier? August 20, 2021 Consortium News
ICTS Associate Director Christina Gurnett, MD, PhD featured speaker at the NextGen Precision Health Discovery Series. August 20, 2021 Consortium News
Research supported by Washington University ICTS finds that antibodies elicited by COVID-19 vaccination effective against delta variant August 17, 2021 Consortium News
Investigator uses Washington University ICTS resources for COVID-19 research and clinical trial efforts July 22, 2021 Consortium News
CTSA Visiting Scholar Program: Gut Interrupted: Modeling Microbiome-Dependent Modulation of Premature Infant Intestinal Vulnerability July 15, 2021 Event
Washington University ICTS supports study that finds COVID-19 vaccine generates immune structures critical for lasting immunity June 29, 2021 Consortium News
If you build it, will they come? Linking researcher engagement and scientific productivity in large infrastructure grants June 28, 2021 Consortium News
Measuring the impact of science; How CTSAs use the Translational Science Benefits Model to show real world benefits June 28, 2021 Consortium News
Washington University ICTS Partnership Development and Sustainability Support Program (PDSS) Awardees Announced June 16, 2021 Consortium News
Washington University ICTS supports new study that suggests, among men, low testosterone levels in the blood are linked to more severe COVID-19 June 16, 2021 Consortium News
Washington University ICTS supports research showing that people who have had a mild case of COVID-19 are left with long-term antibody protection against future disease June 16, 2021 Consortium News
Washington University School of Medicine in St. Louis joins All of Us Research Program with support from the ICTS May 18, 2021 Consortium News
Washington University ICTS helps fund study showing how COVID-19 increases risk of pregnancy complications May 07, 2021 Consortium News
New study funded by Washington University Institute of Clinical and Translational Sciences shows that for breastfeeding moms, COVID-19 vaccinations may also protect babies April 07, 2021 Consortium News
Washington University ICTS investigators find opioid overdose reduced in patients taking buprenorphine March 11, 2021 Consortium News
Washington University ICTS investigators find new evidence COVID-19 antibodies, vaccines less effective against variants March 11, 2021 Consortium News
Washington University ICTS provides framework for unique community collaboration to develop and thrive March 11, 2021 Consortium News
Washington University ICTS investigators find promising role for whole genome sequencing in guiding blood cancer treatment March 11, 2021 Consortium News
Saint Louis University ICTS investigator utilizes funding mechanism to advance research on opioid therapy options March 09, 2021 Consortium News
Washington University Institute of Clinical and Translational Sciences (ICTS) awards 17 investigators as part of the 14th annual Clinical and Translational Research Funding Program (CTRFP) February 26, 2021 Consortium News
COVID-19 vaccines at Washington University School of Medicine February 22, 2021 Consortium News
Washington University ICTS investigators test fluvoxamine repurposed as treatment for COVID, Utilize fully-remote clinical trial to reach participants February 12, 2021 Consortium News
Rapid blood test identifies COVID-19 patients at high risk of severe disease February 12, 2021 Consortium News
Podcast: Washington University ICTS investigators research fluvoxamine repurposed for COVID-19 patients. National, multicenter, fully remote trial underway. January 13, 2021 Consortium News
Washington University ICTS Director welcomes Dr. Anthony Fauci as Gerald Medoff Visiting Professor on January 7 January 13, 2021 Consortium News
Washington University ICTS Researchers Find Fluvoxamine May Prevent Serious Illness in COVID-19 Patients December 18, 2020 Consortium News
Washington University ICTS Community Advisory Board to provide ongoing advice on grant funded by the NIH 's Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiative December 18, 2020 Consortium News
KL2 Alumnus Maximizes Washington University ICTS Options to Gain Skills for Dual Career as Researcher and ICU Clinician December 16, 2020 Consortium News
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm November 18, 2020 Consortium News
Washington University ICTS partner institutions Saint Louis University and Washington University work together to recruit St. Louis residents for trials part of CoVPN November 18, 2020 Consortium News
Doug Lindsay, Washington University ICTS Community Advisory Board Co-chair, appointed to PCORI's Rare Disease Advisory Panel November 04, 2020 Consortium News
Research from Washington University ICTS investigators suggest the eye’s cornea can resist infection from the novel coronavirus. November 04, 2020 Consortium News
CTSA Hubs are uniquely positioned to lead the response to a national health crisis such as COVID-19 October 20, 2020 Poster
Washington University ICTS Associate Director Christina Gurnett Co-Director of Center funded by recent NIH/NCATS Award October 02, 2020 Consortium News
CTRFP Awardee Taps ICTS Resources to Advance Research on Non-Invasive Brain Cancer Diagnosis September 30, 2020 Consortium News
Washington University ICTS community partners assist with recruitment for WashU ACTIV-2 trial August 28, 2020 Consortium News
Washington University ICTS Director featured in podcast, "Where does life in the U.S. stand six months into the pandemic?" August 26, 2020 Consortium News
Oregon Clinical and Translational Research Institute utilizes WashU Translational Science Benefits Model to assess impact of research August 24, 2020 Consortium News
Washington University ICTS investigator developing a method to diagnose brain tumors without any incisions. August 24, 2020 Consortium News
Immunophenotyping the COVID‐19 Hospitalized Patient July 29, 2020 Covid Study
Monocytes and Neutrophils in COVID‐19 July 29, 2020 Covid Study
Clinical Predictors of Longitudinal Antibody Response to SARS‐CoV‐2 July 28, 2020 Covid Study
Understanding Circulating Cytokines and Chemokines in Patients with COVID‐19 July 28, 2020 Covid Study
Artificial Intelligence for the Real‐Time Prediction of Respiratory Deterioration in SARSCoV2 Infected Patients: a Clinical Triage Tool July 28, 2020 Covid Study
Development of Quantitative Imaging Phenotype for COVID‐19 July 28, 2020 Covid Study
Aerosol Characterization in Frontline COVID‐19 Healthcare Settings July 27, 2020 Covid Study
Evaluation of SARS‐CoV2 Papain‐like Protease Inhibitors as a Novel Treatment for COVID‐19 July 27, 2020 Covid Study